194 related articles for article (PubMed ID: 34996857)
1. Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis.
Ji L; Xie W; Fasano S; Zhang Z
Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 34996857
[TBL] [Abstract][Full Text] [Related]
2. Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal.
Ji L; Gao D; Hao Y; Huang H; Wang Y; Deng X; Geng Y; Zhang Z
Rheumatology (Oxford); 2022 Dec; 62(1):181-189. PubMed ID: 35412598
[TBL] [Abstract][Full Text] [Related]
3. Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
Fasano S; Coscia MA; Pierro L; Ciccia F
Lupus; 2021 May; 30(6):991-997. PubMed ID: 33709836
[TBL] [Abstract][Full Text] [Related]
4. Low-dose glucocorticoids should be withdrawn or continued in systemic lupus erythematosus? A systematic review and meta-analysis on risk of flare and damage accrual.
Ji L; Xie W; Zhang Z
Rheumatology (Oxford); 2021 Dec; 60(12):5517-5526. PubMed ID: 33576768
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Zen M; Saccon F; Gatto M; Montesso G; Larosa M; Benvenuti F; Iaccarino L; Doria A
Rheumatology (Oxford); 2020 Jul; 59(7):1591-1598. PubMed ID: 31642908
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
[TBL] [Abstract][Full Text] [Related]
7. Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.
Huang H; Mu L; Zhang Z; Gao D; Hao Y; Zhou W
Arthritis Res Ther; 2021 Oct; 23(1):275. PubMed ID: 34715915
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations.
Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
Clin Rheumatol; 2019 Oct; 38(10):2785-2791. PubMed ID: 31175481
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of effectiveness and safety of glucocorticoid combined with hydroxychloroquine in the treatment of systemic lupus erythematosus rash.
Liang S; Wei Z; Fang H; Guan T
Int J Rheum Dis; 2023 Sep; 26(9):1686-1696. PubMed ID: 37496262
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.
Fasano S; Messiniti V; Iudici M; Coscia MA; Ciccia F
Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36631164
[TBL] [Abstract][Full Text] [Related]
12. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies.
Cai T; Zhao J; Yang Y; Jiang Y; Zhang JA
Lupus; 2022 Dec; 31(14):1714-1725. PubMed ID: 36325952
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
Intern Med; 2019 May; 58(9):1257-1262. PubMed ID: 30626831
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.
Tani C; Elefante E; Signorini V; Zucchi D; Lorenzoni V; Carli L; Stagnaro C; Ferro F; Mosca M
RMD Open; 2019; 5(2):e000916. PubMed ID: 31275608
[TBL] [Abstract][Full Text] [Related]
16. Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre.
Goswami RP; Sit H; Ghosh P; Sircar G; Ghosh A
Clin Rheumatol; 2019 Apr; 38(4):1089-1097. PubMed ID: 30523554
[TBL] [Abstract][Full Text] [Related]
17. Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study.
Sada KE; Katayama Y; Asano Y; Hayashi K; Miyawaki Y; Ohashi K; Katsuyama E; Katsuyama T; Takano-Narazaki M; Matsumoto Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Ichinose K; Sato S; Fujiwara M; Yajima N
Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36167483
[TBL] [Abstract][Full Text] [Related]
18. Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?
Mathian A; Arnaud L; Ruiz-Irastorza G
Autoimmun Rev; 2024 Jan; 23(1):103446. PubMed ID: 37683819
[TBL] [Abstract][Full Text] [Related]
19. Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study.
Hao Y; Ji L; Gao D; Fan Y; Geng Y; Zhang X; Li G; Zhang Z
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35241499
[TBL] [Abstract][Full Text] [Related]
20. Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis.
Tao CY; Shang J; Chen T; Yu D; Jiang YM; Liu D; Cheng GY; Xiao J; Zhao ZZ
Medicine (Baltimore); 2019 Apr; 98(14):e15030. PubMed ID: 30946340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
